Dr Steven Adelsheim Discusses Changing Stigmas Around Mental Illness in Young People
May 21st 2019Steven Adelsheim, MD, clinical professor of psychiatry and behavioral sciences, Stanford University School of Medicine, explained how the stigma surrounding mental health issues can cause delays in treatment, but the increased discussion of mental health on social media may make young people become more comfortable with discussing their experiences and seeking help.
Watch
Dr Martin Makary on How PBMs Impact Drug Pricing, Transparency
May 20th 2019Pharmacy benefit managers (PBMs), have historically been a black box for those paying into them, partly because medications are confusing, explained Martin Makary, MD, MPH, a surgical oncologist and chief of the Johns Hopkins Islet Transplant Center.
Watch
Hochschild Gives Psychiatrists a View of Bridging the Political Chasm
May 20th 2019A discussion with University of California at Berkeley sociologist Arlie Hochschild, PhD, author of the best-seller Strangers in Their Own Land: Anger and Mourning on the American Right, addressed how social psychiatry can help bridge the current political divide.
Read More
Dr David Kingdon on the Principles Underlying the Use of CBT in Psychosis
May 20th 2019The use of cognitive behavioral therapy (CBT) has expanded to patients experiencing psychosis, who can learn to cope with delusional beliefs or hearing voices, explained David Kingdon, MD, professor of mental health care delivery, University of Southampton.
Watch
Dr Lee Schwartzberg: How OneOncology Will Help Community Practices Navigate Cancer Care Landscape
May 18th 2019Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, explains how partnerships like OneOncology can help community practices adapt to the rapidly changing cancer care and diagnostic landscape.
Watch
Dr Susan Mani: How LifeBridge Health Came to Recognize the Importance of SDOH
May 17th 2019Looking at readmissions for congestive heart failure, we realized that the majority of our patients were being readmitted because of care coordination and social determinants of health, explained Susan Mani, MD, vice president of Clinical Transformation and Ambulatory Quality at LifeBridge Health.
Watch
Dr Sebastian Schneeweiss: In 5 Years, Rapid-Cycle Analytics Will Account for Majority of Analyses
May 15th 2019Sebastian Schneeweiss, MD, ScD, professor of medicine and epidemiology, Harvard Medical School and Brigham and Women's Hospital, and co-founder of Aetion, discusses current use of rapid-cycle analytics and what efforts are needed to improve understanding and uptake.
Watch
Dr Howard Burris Discusses the Role of Clinical Trials in Maintaining Progress in Cancer Care
May 14th 2019Encouraging clinical trial participation is the only way we’ll get the answers to the questions we need for future generations, explained Howard A. "Skip" Burris, III, MD, FACP, FASCO, president, clinical operations, and chief medical officer of Sarah Cannon Research Institute.
Watch
Rose Gerber: Keep the Patient in Mind During Clinical Trials
May 13th 2019Rose Gerber, director of patient advocacy and education for the Community Oncology Alliance, discusses the importance of patient education in encouraging clinical trial participation, as well as the importance of trials being patient centered.
Watch
Katie Goodman on the Importance of Informing Patients of Clinical Trials
May 11th 2019Clinical trials should be a part of the conversation early and throughout the cancer journey, explained Katie Goodman, RN, BSN, CCRP, director of clinical research, Florida Cancer Specialists & Research Institute.
Watch
Addressing Chronic Conditions to Improve Health of Employees and Decrease Costs
May 10th 2019Programs that address chronic conditions have the potential to improve employee satisfaction, reduce costs, and improve employee health, said speakers at the Midwest Business Group on Health’s 39th Annual Conference, held May 8-9 in Chicago, Illinois.
Read More
Dr Martin Makary Discusses Hospitals Being Required to Post Prices of Services Online
May 9th 2019Martin Makary, MD, MPH, a surgical oncologist and chief of the Johns Hopkins Islet Transplant Center, dicscusses how hospitals have responded to having to post standard charges of their services online by uploading their chargemasters.
Watch
Building Trust, Engaging Employees, and Improving Healthcare
May 9th 2019Trust is crucial when employers are trying to have successful healthcare programs and engage employees to change behaviors, said panelists at the Midwest Business Group on Health’s 39th Annual Conference, held May 8-9 in Chicago, Illinois.
Read More
Learning From Other Countries and Dispelling Myths of a Single-Payer System
May 9th 2019As the United States debates the feasibility and benefits or harms of a single-payer system, the important thing is to have a fact-based discussion and to ask questions, Jan Berger, MD, JD, chief executive officer of Health Intelligence Partners and medical director of the Midwest Business Group on Health (MBGH), said during a session at MBGH’s 39th Annual Conference, held May 8-9 in Chicago, Illinois.
Read More
Dr Susan Mani on the Importance of Process Measures When Determining Value of SDOH Initiatives
May 7th 2019If you wait for lagging outcomes, such as readmissions, it may be months before you realize if the initiative is working or not, explained Susan Mani, MD, vice president of Clinical Transformation and Ambulatory Quality at LifeBridge Health.
Watch
New Innovations and Cures Require Overhauling Insurance and Benefit Design
May 5th 2019Healthcare is very comfortable with treating a disease, but it’s not as good with handling cures. However, the advent of gene therapy and precision medicine means more and more expensive cures are coming down the pipeline, said panelists on the last day of Asembia’s 15th annual Specialty Pharmacy Summit, held April 29 to May 2 in Las Vegas, Nevada.
Read More
Policy Changes Need to Address OOP Costs to Have a Real Impact on Patients
May 3rd 2019Out-of-pocket (OOP) costs remain a problem, and even patients who are receiving co-pay assistance worry about these expenses. Unfortunately, charitable foundations that provide financial assistance are under increasing strain as demand rises, with funds running out of money quickly, explained Ayesha Azam, senior director of medical affairs, Patient Access Network Foundation.
Read More
Claims Data Can Provide New Insight Into the Condition of Patients With MS
May 3rd 2019Analyses of real-world data have broadened the understanding of multiple sclerosis (MS) and provided a snapshot into patient conditions and healthcare costs in the years leading up to and the years after an MS diagnosis, explained Bruce Pyenson, FSA, MAAA, Principal, Consulting Actuary, Milliman, Inc, during a session highlighting findings of a recent Milliman white paper at Asembia’s 15th annual Specialty Pharmacy Summit, held April 29 to May 2 in Las Vegas, Nevada.
Read More
Cancer Moonshot Agenda Continues on With the Biden Cancer Initiative
May 2nd 2019During a session at Asembia’s 15th annual Specialty Pharmacy Summit, Greg Simon, president, Biden Cancer Initiative, outlined commitments that came out of the Cancer Moonshot, the work of the Biden Cancer Initiative, and ongoing challenges that patients with cancer face.
Read More
Matt Farber Discusses Pharmacist Role in Managing Cancer Care Costs
May 2nd 2019New technologies are enabling pharmacists to play a bigger role in managing overall care delivery and the cost of care for patients with cancer, explained Matt Farber, MA, senior director of Patient Care and Advocacy for Walgreens.
Watch
Gottlieb: There Couldn't Have Been a Better Time to Be at the FDA
May 2nd 2019During his keynote speech at Asembia’s 15th annual Specialty Pharmacy Summit, Scott Gottlieb, MD, reflected on governing principles he learned during his time as FDA commissioner, highlighted secular trends for which FDA wrote modern rules, and outlined ongoing reimbursement challenges. He even discussed the likelihood of some form of Medicare for All passing.
Read More
Rule Eliminating Rebates Leaves Plenty of Uncertainty
May 1st 2019A policy from the Trump administration to benefit patients and alleviate the high cost of prescription drugs would eliminate rebates from pharmaceutical companies to pharmacy benefit managers. However, there is still a lot of uncertainty around the rule. Two speakers from Deloitte Consulting LLP outlined what models are expected to result from the changes to rebates and how they will affect various stakeholders in healthcare.
Read More